Skip to main content
Close

Leukemia & Bone Marrow Transplant

Protocols

Bone Marrow Transplant

BMTLPDRIT

Pre-Emptive riTUXimab Therapy of Epstein-Barr Virus (EBV) Related Post-Transplant Lymphoproliferative Disease


BMTMM0301

Conditioning therapy for autologous stem cell transplant using high dose melphalan in the treatment of multiple myeloma


BMTIVBUCY

Myeloablative conditioning therapy prior to autologous and allogeneic hematopoietic stem cell transplantation for myeloid malignancies using IV busulfan and cyclophosphamide


MYHDC

Single dose cyclophosphamide priming therapy for multiple myeloma prior to autologous stem cell transplant.

Leukemia & Other Myeloid Neoplasms

ULKAMLAS

Therapy of Acute Myeloid Leukemia Using azaCITIDine and SORAfenib


LKAMLCYT

Therapy of Acute Myeloid Leukemia Using Low dose Cytarabine


LKANAG

Anagrelide as second-line treatment of thrombocytosis related to myeloproliferative disorders


LKATOATRA

First-Line Induction and Consolidation Therapy of Acute Promyelocytic Leukemia Using Arsenic Trioxide and Tretinoin (All-Trans Retinoic Acid)


LKATOP

First-Line Induction and Consolidation Therapy of Acute Promyelocytic Leukemia Using Arsenic Trioxide, Tretinoin (All-Trans Retinoic Acid) and DAUNOrubicin


LKATOR

Induction and Consolidation Therapy of Relapsed Acute Promyelocytic Leukemia Using Arsenic Trioxide


ULKCMLB

Treatment of Chronic Myeloid Leukemia Using Bosutinib 


LKCMLI

Therapy for Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia Using Imatinib


ULKCMLD

Treatment of Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia Using Dasatinib


ULKCMLN

Treatment of Chronic Myeloid Leukemia Using Nilotinib


ULKCMLP

Treatment of Chronic Myeloid Leukemia and Ph+ Acute Lymphoblastic Leukemia Using Ponatinib 


ULKMDSA

Therapy of Myelodysplastic Syndrome using Azacitidine


ULKMDSL

Therapy of Myelodysplastic Syndrome using Lenalidomide


ULKMFRUX

Treatment of Symptomatic Myelofibrosis with Ruxolitinib


LKPEGIFN

Peginterferon Alfa-2a Therapy of Chronic Myeloid Neoplasms and Hypereosinophilic Syndrome


LYCODOXMR

Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Cyclophosphamide, vinCRIstine, DOXOrubicin, Methotrexate, Leucovorin (CODOX-M) and riTUXimab

LYIVACR

Treatment of Burkitt’s Lymphoma and Leukemia (ALL-L3) with Ifosfamide, Mesna, Etoposide, Cytarabine (IVAC) and riTUXimab

Terms of use

The information contained in these documents is a statement of consensus of BC Cancer Agency professionals regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult these documents is expected to use independent medical judgement in the context of individual clinical circumstances to determine any patient's care or treatment. 

Use of these documents is at your own risk and is subject to the BC Cancer Agency's terms of use.

Tab Heading
Tab Heading
SOURCE: Leukemia & Bone Marrow Transplant ( )
Page printed: . Unofficial document if printed. Please refer to SOURCE for latest information.

Copyright © BC Cancer Agency. All Rights Reserved.

    Copyright © 2017 Provincial Health Services Authority